Primary care sequential use of FIB-4 and the enhanced liver fibrosis test to stratify patients with non-alcoholic fatty liver disease increases cirrhosis detection and reduces referrals of patients with mild disease-2 year study analysis

被引：2

作者：

Srivastava, A. ^{[1
]}

Gailer, R. ^{[2
]}

Demma, S. ^{[1
]}

Warner, A. ^{[3
]}

Suri, D. ^{[4
]}

Morgan, S. ^{[5
]}

Sennett, K. ^{[6
]}

Thorburn, D. ^{[1
]}

Parkes, J. ^{[1
,7
]}

Tsochatzis, E. ^{[1
]}

Rosenberg, W. ^{[1
]}

机构：

[1] UCL Inst Liver & Digest Hlth, Dept Hepatol, London, England

[2] UCL Inst Liver & Digest Hlth, Primary Care & Populat Hlth, London, England

[3] UCL, Primary Care & Populat Hlth, London, England

[4] Whittington Hosp, Dept Hepatol, London, England

[5] Camden CCG, Primary Care, London, England

[6] Islington CCG, Primary Care, London, England

[7] Univ Southampton, Publ Hlth Sci & Med Stat, Southampton, Hants, England

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30397-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-121

引用

页码：S68 / S68

页数：1

共 50 条

[1] PRIMARY CARE SEQUENTIAL USE OF FIB-4 AND THE ENHANCED LIVER FIBROSIS TEST TO STRATIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER ACIDE DOUBLES CIRRHOSIS DETECTION AND REDUCES REFERRALS OF PATIENTS WITH MILD DISEASE
Srivastava, A.
Gailer, R.
Demma, S.
Warner, A.
Suri, D.
Morgan, S.
Tanwar, S.
Sennett, K.
Thorburn, D.
Parkes, J.
Tsochatzis, E.
Rosenberg, W.
JOURNAL OF HEPATOLOGY, 2016, 64 : S474 - S475
[2] FIB-4 Compared to Ultrasonography for the Assessment of Liver Fibrosis in Diabetics With Non-alcoholic Fatty Liver Disease
Kumar, Sateesh
Ali, Zeeshan
Naveed, Shabnam
Ahmed, Masroor
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1492 - S1492
[3] Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
Kumari, Bandana
Kumar, Ramesh
Sharma, Sadhana
Banerjee, Ayan
Kumar, Visesh
Kumar, Pawan
Chaudhary, Neha
Kumar, Sushil
Raj, Khushboo
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
[4] Temporal assessment of the non-invasive fibrosis scores FIB-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS) in a retrospective cohort study among patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Perez-Carreras, M.
Munoz Codoceo, C.
Ortega, M. M.
Castro, M. R.
Alfonso, F. M.
Algibez, A. M.
Gil, Y. R.
Tortajada, G. C.
JOURNAL OF HEPATOLOGY, 2018, 68 : S565 - S566
[5] Health economics of the enhanced liver fibrosis test in the detection of advanced liver fibrosis in patients with non-alcoholic fatty liver disease in the UK
Younossi, Zobair
Stepanova, Maria
Paik, James
Nader, Fatema
Henry, Linda
Pollock, Richard
JOURNAL OF HEPATOLOGY, 2023, 78 : S857 - S858
[6] Reply to: "FIB-4 cut off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease"
Tsochatzis, Emmanuel A.
Srivastava, Ankur
Rosenberg, William
JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 217 - 218
[7] IMPORTANCE AND UTILITY OF FIBROSCAN IN ASSOCIATION WITH FIB-4, FOR ASSESSMENT OF LIVER FIBROSIS IN T2DM FEMALE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Padhye, D.
Tanna, S.
James, A.
Nair, N.
Shah, M.
Kovil, R.
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A190 - A190
[8] FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease
Shah, Samir
Dhami-Shah, Hiteshi
Kamble, Swati
Shukla, Akash
JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 216 - 217
[9] Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
Unsal, Ilknur Ozturk
Calapkulu, Murat
Sencar, Muhammed Erkam
Cakal, Basak
Ozbek, Mustafa
SCIENTIFIC REPORTS, 2022, 12 (01)
[10] Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
İlknur Ozturk Unsal
Murat Calapkulu
Muhammed Erkam Sencar
Basak Cakal
Mustafa Ozbek
Scientific Reports, 12

← 1 2 3 4 5 →